Charles River Labs Tops Q1 2026 Outlook, Reaffirms Guidance
Company reports $996 million revenue, $2.06 non-GAAP EPS, and maintains full-year targets despite organic revenue decline. Charles River Laboratories posted Q1 2026 revenue of $996 million, up 1.2% year over year, exceeding its prior outlook. Non-GAAP EPS fell 12% to $2.06